Anderson Burton Collier, MD
Division Chief Hem/OncFellowship
- Pediatric Hematology/Oncology - University of Texas Southwestern Medical Center, 2004
Internship
- Pediatrics - Children's Medical Center of Dallas, 1999
Residency
- Pediatrics - Children's Medical Center of Dallas, 2001
Education
- M.D. - Vanderbilt University School of Medicine, 1998
Board Certifications
- American Board of Pediatrics/Hematology-Oncology
-
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort; JNCI: Journal of the National Cancer Institute; (2025).
-
Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemia; Pediatric Blood & Cancer; (2023).
-
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia; Infection Control & Hospital Epidemiology; (2023).
-
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group; Pediatric Blood & Cancer; (2021).